| Robert D Gourley, MD | |
|
920 S Bryant Ave, Ste 100, Edmond, OK 73034-5797 | |
| (405) 341-4238 | |
| (405) 340-0269 |
| Full Name | Robert D Gourley |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 49 Years |
| Location | 920 S Bryant Ave, Edmond, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093704793 | NPI | - | NPPES |
| 100212730A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 10888 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| O U Medical Center | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Edmond Regional Eye Associates Inc | 9133159924 | 3 |
News Archive
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix™ Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system. The product is now available in Europe and other international markets; the Company plans to launch it in the U.S. this quarter.
University of Missouri leaders celebrated a nanomedicine milestone today as they announced the creation of a new drug development company. The new company forms a partnership between university researchers and an international pharmaceutical firm to advance testing of a potential cancer treatment created at MU.
A post in the Center for Global Health Policy's "Science Speaks" blog highlights a White House call "with faith-based organizations Wednesday afternoon to discuss efforts in the Horn of Africa to combat the extensive famine brought on by a severe drought in the region, the worst seen in decades."
Multiple sclerosis is caused by a combination of genetic and environmental factors. For a long time, pathogens were believed to be such external influences. According to scientists from the Max Planck Institute of Neurobiology in Martinsried, however, it is apparently not harmful bacteria that trigger multiple sclerosis, but beneficial ones - specifically, the natural intestinal flora, which every human being needs for digestion.
› Verified 4 days ago
| Entity Name | Edmond Regional Eye Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205949609 PECOS PAC ID: 9133159924 Enrollment ID: O20050822000610 |
News Archive
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix™ Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system. The product is now available in Europe and other international markets; the Company plans to launch it in the U.S. this quarter.
University of Missouri leaders celebrated a nanomedicine milestone today as they announced the creation of a new drug development company. The new company forms a partnership between university researchers and an international pharmaceutical firm to advance testing of a potential cancer treatment created at MU.
A post in the Center for Global Health Policy's "Science Speaks" blog highlights a White House call "with faith-based organizations Wednesday afternoon to discuss efforts in the Horn of Africa to combat the extensive famine brought on by a severe drought in the region, the worst seen in decades."
Multiple sclerosis is caused by a combination of genetic and environmental factors. For a long time, pathogens were believed to be such external influences. According to scientists from the Max Planck Institute of Neurobiology in Martinsried, however, it is apparently not harmful bacteria that trigger multiple sclerosis, but beneficial ones - specifically, the natural intestinal flora, which every human being needs for digestion.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert D Gourley, MD 920 S Bryant Ave, Ste 100, Edmond, OK 73034-5797 Ph: (405) 341-4238 | Robert D Gourley, MD 920 S Bryant Ave, Ste 100, Edmond, OK 73034-5797 Ph: (405) 341-4238 |
News Archive
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix™ Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system. The product is now available in Europe and other international markets; the Company plans to launch it in the U.S. this quarter.
University of Missouri leaders celebrated a nanomedicine milestone today as they announced the creation of a new drug development company. The new company forms a partnership between university researchers and an international pharmaceutical firm to advance testing of a potential cancer treatment created at MU.
A post in the Center for Global Health Policy's "Science Speaks" blog highlights a White House call "with faith-based organizations Wednesday afternoon to discuss efforts in the Horn of Africa to combat the extensive famine brought on by a severe drought in the region, the worst seen in decades."
Multiple sclerosis is caused by a combination of genetic and environmental factors. For a long time, pathogens were believed to be such external influences. According to scientists from the Max Planck Institute of Neurobiology in Martinsried, however, it is apparently not harmful bacteria that trigger multiple sclerosis, but beneficial ones - specifically, the natural intestinal flora, which every human being needs for digestion.
› Verified 4 days ago
Bradley Don Britton, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 14701 N Santa Fe Ave, Edmond, OK 73013 Phone: 405-752-2733 Fax: 405-752-2172 | |
Mrs. Laura Sarfatis Miles, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 912 Nw 139th Street Pkwy, Edmond, OK 73013 Phone: 405-608-4447 Fax: 405-286-1261 | |
Jeffrey T Shaver, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3840 South Boulevard, Suite 101, Edmond, OK 73013 Phone: 405-471-5252 Fax: 405-726-8530 | |
Brian Dale Morgan, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 14701 N Santa Fe Ave, Edmond, OK 73013 Phone: 405-752-2733 Fax: 405-752-2172 | |
Dr. Thomas C Wolf, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3431 S Boulevard St, Suite 106, Edmond, OK 73013 Phone: 405-562-2036 Fax: 405-562-2116 | |
Dr. Sandeep N Shah, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1851 S Kelly Ave Ste A, Edmond, OK 73013 Phone: 405-607-6699 Fax: 405-607-6685 |